Fulcrum Therapeutics SG&A Expense (TTM) Trends

Fulcrum Therapeutics Inc (FULC)

3.77 -0.23 (-5.75%) USD | NASDAQ | Sep 27, 16:00

3.84 +0.07 (+1.86%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
June 30, 2024	40.13M
March 31, 2024	40.21M
December 31, 2023	41.67M
September 30, 2023	41.93M
June 30, 2023	41.68M
March 31, 2023	42.46M
December 31, 2022	41.69M
September 30, 2022	41.27M
June 30, 2022	40.19M
March 31, 2022	35.78M
December 31, 2021	30.52M
September 30, 2021	26.68M

Date	Value
June 30, 2021	23.36M
March 31, 2021	21.83M
December 31, 2020	21.39M
September 30, 2020	19.93M
June 30, 2020	18.13M
March 31, 2020	15.61M
December 31, 2019	13.14M
September 30, 2019	11.13M
June 30, 2019	9.748M
March 31, 2019	9.175M
December 31, 2018	8.314M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

11.13M

Minimum

Sep 2019

42.46M

Maximum

Mar 2023

30.44M

Average

33.15M

Median

SG&A Expense (TTM) Benchmarks